Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in alleviating symptoms. (Getty Images) Tavapadon, a drug being tested to ...
Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...
Scientists in Norway and Sweden have discovered a potential breakthrough for blood tests to detect Parkinson’s years before ...
(Reuters) -AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's disease, the company said on Thursday. Patients showed a statistically significant ...
Depression in older adults may sometimes signal the early stages of Parkinson’s disease or Lewy body dementia. Researchers found that depression often appears years before diagnosis and remains ...
AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson's disease on Monday and said it's on track to seek approval for the drug from the Food and Drug ...
13hon MSN
A CT man has a life-altering disease. Now, he’s the first in a clinical trial seeking a breakthrough
A Connecticut resident was diagnosed with a life-altering disease almost a year ago and while waiting to be seen at a UConn Health clinic, his wife spotted a flyer about a study that’s seeking a ...
Tavapadon, a drug being tested to treat early Parkinson's disease, has shown great promise in a Phase III trial by AbbVie, the pharmaceutical company announced this week. Parkinson’s disease, which is ...
AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said it’s on track to seek approval for the drug from the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results